On April 24, Ge Longhui Pharmaceutical (002393.SZ) released its report for the first quarter of 2024. Operating income for the reporting period was 365 million yuan, up 8.71% year on year; net profit attributable to shareholders of listed companies was 59.1556 million yuan, up 27.22% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 58.7736 million yuan, up 29.71% year on year; basic earnings per share were 0.32 yuan.
力生制药(002393.SZ)：一季度净利润5915.56万元 同比增长27.22%
Lisheng Pharmaceutical (002393.SZ): Net profit of 59.1556 million yuan in the first quarter increased 27.22% year-on-year
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.